EEBA Program (PDF/3MB) - EEBA - Annual Meeting

Table of contentsINVITED LECTURE: THOMAS REINHARD – ENDOTHELIAL FAILURE:WHEN TO PERFORM PK, DSAEK OR DMEK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27Standardized coding and labeling for ocular tissue . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28Eurocet 128: supporting the implementation of the European Coding Systemfor traceability of tissues and cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29Evaluation of medical influences on cornea donation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30Mental attitudes concerning cornea donation in a non medically educatedand a professional medical cohort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31Worldwide Eye Banking (WEB) project: international survey of demand and supply. . . . . . . . . . . . 32An evaluation of total blood and plasma volume calculations in eye and tissue banking . . . . . . . . 33Evaluation of the decontamination methods of donor cornea . . . . . . . . . . . . . . . . . . . . . . . . . 34Use of five-year corneal graft survival for the validation of eye bank quality standards . . . . . . . . . . 35INVITED LECTURE: MASSIMO BUSIN – ULTRATHIN DSAEK – THE PRESENT STATUS . . . . . 36Precutting of donor corneas for posterior lamellar keratoplasty . . . . . . . . . . . . . . . . . . . . . . . . 37Predictability of Pre-cut Single-pass Ultra-thin DSAEK lamellae thickness witha novel operator-independent hands-free mechanical microkeratome system . . . . . . . . . . . . . . 38Study of stromal femtosecond laser ablation for deep corneal cut optimization . . . . . . . . . . . . . . 39Surface topography and 3-dimensional optical profiling of femtosecond and novelmechanical microkeratome dissected posterior human corneal discs for DSAEK . . . . . . . . . . . . . 40Ultra- thin Descemet Stripping Automated Endothelial Keratoplasty-first results . . . . . . . . . . . . . 41Initial endothelial cell loss after DSAEK using a novel donor inserter. . . . . . . . . . . . . . . . . . . . . . 42Posterior lamellar keratoplasty- postoperative results after modification of surgical technique. . . . . 43Mid-term results on visual acuity and stability after Descemet membrane endothelialkeratoplasty (DMEK) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44Endothelial cell density after Descemet membrane endothelial keratoplasty (DMEK):1 to 6 - year Follow-up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45The role of the donor in DMEK surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46INVITED LECTURE: DONALD TAN – EYE BANKING CHALLENGES IN ASIA –CAN THEY BE OVERCOME? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47Electrolyte composition of four eye bank media during corneal preservation . . . . . . . . . . . . . . . 48Integrity of human corneal epithelium maintained in organ-culture using CorneaMax® . . . . . . . . . 49Prospective clinical evaluation of hypothermic vs organ cultured corneal grafts . . . . . . . . . . . . . . 50A novel objective method to evaluate the overall quality of corneal tissue usedfor comparative study between two hypothermic preservation media . . . . . . . . . . . . . . . . . . . 51European study on reliability assessment of endothelial cell count in eye banks:The Euro-Keratotest study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52Evaluation of donor corneas during storage by full-field optical coherence tomography . . . . . . . . 53ROCK inhibitor enhances adhesion and wound healing on human corneal endothelialcells ex vivo and in vitro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54Delivery of molecules into corneal endothelium using nanoparticlesactivated by femtosecond laser pulses: proof of concept . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55DNA damage in donor corneal endothelium upon transfer from Optisol GS to Organ Culture . . . . . 56XXV ANNUAL MEETING OF THE EUROPEAN EYE BANK ASSOCIATION Zagreb, Croatia 18/19 January 2013 25